Bolivia Legal Hierarchy: Law, Supreme Decree, and Ministerial Resolution

Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

Bolivian device rules form a three-layer structure. The first layer is law (Ley): Ley N° 1737 of December 17, 1996 establishes the scope of jurisdiction and the policy objectives. The second layer is supreme decree (Decreto Supremo): Decreto Supremo N° 25235 of November 30, 1998 and Decreto Supremo N° 2905 of September 21, 2016 implement the regulation of the law and the creation of the agency respectively. The third layer consists of ministerial resolutions (Resolución Ministerial) and manuals: RM N° 010 (the device manual) and RM N° 0265 of May 25, 2018 (fees and procedures) carry all of the operational detail. GRZAN’s conclusion is that the law decides whether the state can regulate, while the ministerial resolutions decide how to file, how long it takes, and how much it costs. For scheduling and budgeting, the third layer is the direct lever, because every date and every fee that a project plan depends on is written there, not in the law itself.

The layering also explains why Bolivian device requirements are best read in three passes. The first pass through the law answers the scope question: what the state claims the power to regulate, and which product categories are named. The second pass through the decrees answers the institutional question: who implements, under what independence, and with which record obligations such as the representation filing of Article 42 and the packaging identification of Article 149. The third pass through the resolutions and the manual answers the operational question: which form, which fee, which timeline, which review stages. Reading the layers in that order prevents the most common drafting error, which is filling a dossier with operational detail while the scope and institutional anchors remain unverified.

2. Legal basis

InstrumentNumber / referencePublication dateProvision
Ley del Medicamento (Medicines Law)Ley N° 1737December 17, 1996Article 2
Decreto Supremo (regulation of the Medicines Law)Decreto Supremo N° 25235November 30, 1998Articles 42 and 149
Decreto Supremo (creation of AGEMED)Decreto Supremo N° 2905September 21, 2016Article 2
Resolución Ministerial (fees and procedures)Resolución Ministerial N° 0265May 25, 2018Full text

3. Expert insights

Insight one: the three layers span nearly 30 years, and all of them are in force. Instruments from 1996, 1998, 2016, and 2018 apply at the same time. This sedimentary structure of rules is not rare in Latin America, but it means that reading only the newest document misses hard obligations buried in the older provisions, such as the packaging identification obligation of Article 149. A compliance file that starts and ends with the latest manual is incomplete by construction.

Insight two: the lower the layer, the faster it changes. The legal layer has not moved for nearly 30 years, while the ministerial resolution layer can be adjusted comparatively quickly. A company should allocate its regulatory tracking resources according to the frequency of change, not according to the rank of the instrument, which in practice means the monitoring budget concentrates on resolutions, circulars, and website notices rather than on statutes.

Insight three: regional rules are the fourth-layer variable. Bolivia is a member of the Andean Community (CAN), and since July 8, 2024 it has been a full member of MERCOSUR, with an obligation to progressively absorb the existing MERCOSUR regulatory body within 4 years. This layer does not alter the current three-layer structure, but within the window period it transmits new requirements down into the third layer (see article 19 for details), which means that the fixed fee and procedure table of today may be revised on a regional timetable rather than a purely national one.

Insight four: the hierarchy tells you where an answer is authoritative. When two sources appear to conflict, the layer of each source settles the question: a manual cannot override a decree, and a decree cannot override the law. In day-to-day work this resolves the frequent small disputes about interpretation, such as whether a checklist habit inherited from a previous importer can override a written requirement in the manual, or whether a fee quoted verbally can differ from the schedule in RM N° 0265. An answer located in a lower layer always yields to a written answer in a higher one, which is why the four-layer list below records not just the documents but their rank.

4. Practical recommendations

The three recommendations below operationalize the layer model. The four-layer list gives the structure, the differentiated tracking frequency allocates attention where change actually happens, and the re-run of the older provisions protects against the sedimentation risk described in the insights. Together they turn a static legal analysis into a maintenance routine that a regulatory coordinator can run without specialist input, escalating to counsel only when a layer boundary is genuinely in doubt.

The payoff of the layer model appears at moments of change. When a new resolution is issued, the list shows immediately which lower-layer documents must be re-read and which upper-layer anchors remain untouched; when the MERCOSUR window produces new requirements, the list shows where they are expected to land. In both cases the answer arrives in hours rather than days, because the structure of the analysis was built before the change, not after it.

  1. Build a four-layer list: one column each for laws, supreme decrees, ministerial resolutions, and regional rules, each annotated with its date of entry into force and the date of the most recent verification.
  2. Set the tracking frequency for ministerial resolutions to quarterly and for the legal layer to annual.
  3. Re-run the older provisions at the initiation of every new project, focusing on whether Articles 42 and 149 of Decreto Supremo N° 25235 are reflected in the documentation.

5. Verification checklist

  • □ Has a four-layer list of regulations been built and maintained
  • □ Have the entry-into-force dates and the most recent verification dates of each layer been recorded
  • □ Has the applicability of the older provisions (Articles 42 and 149) in this project been assessed
  • □ Has the current version of the ministerial resolutions been downloaded and archived
  • □ Have changes in the regional rules (CAN, MERCOSUR) been brought into the tracking scope

Regulatory information verified as of October 29, 2026.

GRZAN supports manufacturers, importers, and authorized representatives with medical device registration in Bolivia, covering dossier preparation, local entity coordination, and regulatory strategy. Contact info@grzanglobal.com for project inquiries.

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail